Adeno-associated viruses (AAV) have emerged as pivotal delivery vehicles for gene therapy due to their overall safety (less immunogenic), efficiency (broad tropism), and long-term gene expression.
Transfection is a crucial non-viral technique for introducing DNA or RNA into cells, yet achieving high efficiency and consistency can be challenging, particularly with difficult cell types.
A novel cationic nanotechnology called jetOPTIMUS ® was created to increase the effectiveness of DNA transfection in adherent cells, including difficult-to-transfect cells. Transfection with ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback